454 related articles for article (PubMed ID: 24602858)
1. Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study.
Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y; Hara M; Sakata Y; Hamasaki T; Nishino M
EuroIntervention; 2014 Dec; 10(8):924-33. PubMed ID: 24602858
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study.
Chieffo A; Buchanan GL; Parodi G; Versaci F; Bianchi RM; Valenti R; Saccà S; Mongiardo A; Span S; Migliorini A; Spaccarotella C; Reimers B; Antoniucci D; Indolfi C; Ferrari A; Maehara A; Mintz GS; Colombo A
EuroIntervention; 2014 Dec; 10(8):916-23. PubMed ID: 24974806
[TBL] [Abstract][Full Text] [Related]
3. Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study.
Kochman J; Pietrasik A; Rdzanek A; Ścibisz A; Pawlak M; Filipiak KJ; Opolski G
Cardiol J; 2013; 20(3):247-53. PubMed ID: 23788298
[TBL] [Abstract][Full Text] [Related]
4. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
[TBL] [Abstract][Full Text] [Related]
5. Serial optical coherence tomography-based observation of strut coverage on drug-eluting stent crossing side-branch vessels.
Lee SY; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
J Invasive Cardiol; 2012 Nov; 24(11):569-73. PubMed ID: 23117310
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
[TBL] [Abstract][Full Text] [Related]
7. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.
Kim S; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Cho YK; Nam CW; Hur SH; Jang Y; Hong MK
Am J Cardiol; 2013 Jan; 111(1):1-5. PubMed ID: 23040589
[TBL] [Abstract][Full Text] [Related]
8. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
[TBL] [Abstract][Full Text] [Related]
11. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
[TBL] [Abstract][Full Text] [Related]
12. A serial 3- and 9-year optical coherence tomography assessment of vascular healing response to sirolimus- and paclitaxel-eluting stents.
Tomaniak M; Kołtowski Ł; Pietrasik A; Rdzanek A; Jąkała J; Proniewska K; Malinowski K; Mazurek T; Filipiak KJ; Brugaletta S; Opolski G; Kochman J
Int J Cardiovasc Imaging; 2019 Jan; 35(1):9-21. PubMed ID: 30168010
[TBL] [Abstract][Full Text] [Related]
13. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography.
Li S; Wang Y; Gai L; Yang T; Liu H; Wang Z; Bai Q; Xu X; Chen Y
Int J Cardiol; 2013 Jan; 162(3):166-71. PubMed ID: 21641053
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the peri-strut low intensity area following sirolimus- and paclitaxel-eluting stents implantation: insights from an optical coherence tomography study in humans.
Otake H; Shite J; Ikeno F; Shinke T; Teramoto T; Miyoshi N; Ako J; Honda Y; Fitzgerald PJ; Hirata K
Int J Cardiol; 2012 May; 157(1):38-42. PubMed ID: 21168926
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up.
Kim BK; Hong MK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y
Int J Cardiol; 2013 Oct; 168(5):4617-23. PubMed ID: 23932862
[TBL] [Abstract][Full Text] [Related]
17. Difference in neointimal coverage at chronic stage between bare metal stent and sirolimus-eluting stent evaluated at stent-strut level by optical coherence tomography.
Ikuta S; Kobuke K; Iwanaga Y; Nakauchi Y; Yamaji K; Miyazaki S
Heart Vessels; 2014 May; 29(3):320-7. PubMed ID: 23793881
[TBL] [Abstract][Full Text] [Related]
18. Difference of neointimal growth patterns in bifurcation lesions among four kinds of drug-eluting stents: an optical coherence tomographic study.
Yoshimura T; Tanaka A; Mori N; Nakamura D; Taniike M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
Catheter Cardiovasc Interv; 2014 Nov; 84(5):742-9. PubMed ID: 24497273
[TBL] [Abstract][Full Text] [Related]
19. Neointimal coverage of zotarolimus-eluting stent at 1, 2, and 3 months' follow-up: an optical coherence tomography study.
Hashikata T; Tojo T; Namba S; Kitasato L; Hashimoto T; Kameda R; Shimohama T; Yamaoka-Tojo M; Ako J
Heart Vessels; 2016 Feb; 31(2):206-11. PubMed ID: 25362579
[TBL] [Abstract][Full Text] [Related]
20. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.
Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]